The AbC-19 Rapid Test is an immunoassay designed to detect neutralising IgG antibodies, enclosed in a compact, disposable plastic cassette. This Rapid Antibody Test was developed using the same antigen that the AstraZeneca vaccine is based on.

The AbC-19™ Rapid Test is specifically designed to detect those IgG antibodies which bind to the trimeric spike protein. These are the same antibodies produced by the vaccines:

  • If IgG antibodies to SARS-CoV-2 are present in the sample, they form a complex with the antigen and gold labelled marker protein and are captured at the test line producing a pink purple line.

  • If no IgG antibodies to SARS-CoV-2 are present, no line appears.

  • The test results are clearly visible in the result window after 20 minutes.

After 20 minutes, the AbC-19™ Rapid Test has been shown to have a relative sensitivity of 98% and a relative specificity of 99.6%.

Longterm high-volume production capacity available

For more details:



At Sumner Group Health we are committed to help combat fraudulent activity in connection with our own personal protective equipment (PPE) products and the COVID-19 pandemic.

The COVID-19 pandemic has generated a desperate demand for PPE to help healthcare providers and others to protect themselves and the people around them from the spread of the COVID-19 virus. 

Unfortunately, the demand has established a perfect environment for criminals seeking to take advantage of would-be consumers through elaborate fraud schemes where criminals promise to deliver large quantities of product that they do not actually possess. These deceptive practices frequently involve the non-delivery products after a buyer has remitted payment to the fraudsters.

To help combat COVID-19 related fraud, we urge you to verify that you are in fact engaging with Sumner Group Health, or one of our authorised distributors, and not an imposter, by calling our headquarters in the UAE on +971 4 244 3730 or by emailing